The history of Sildenafil presents a complex picture for those considering investment. While the initial launch generated substantial profits, the end of its intellectual property protection opened the floodgates to generic competitors, dramatically eroding revenue. This creates a unique dilemma for drug manufacturers depending on comparable blockb

The story of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its intellectual property lapse created a flood of lower-priced alternatives , significantly eroding its dominance. While certain pharmaceutical companies may attempt to capitalize on male sexu